Kaitlin M. Kestenberg-Messina is COO and SVP, Compliance of ADMA BIOLOGICS, INC. (ADMA). 8 SEC Form 4 filings on record going back to 2024, most recently on 29 July 2026. Most recent open-market trade: sold $158K of ADMA on 11 March 2026. Lifetime open-market sales: $158K.
Recent transactions
17
The latest 17 SEC Form 4 transactions reported by Kaitlin M. Kestenberg-Messina.
InsiderAlpha's records for Kaitlin M. Kestenberg-Messina go back to 2024: 8 primary Form 4 filings, an average of 2.7 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kaitlin M. Kestenberg-Messina files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Adam S. Grossman - $1.41M in ADMA purchases and sales in the last 12 months
Jerrold B. Grossman - $251K in ADMA purchases and sales in the last 12 months
Steve Elms - $217K in ADMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Kaitlin M. Kestenberg-Messina is a corporate insider, tracked as COO and SVP, Compliance of ADMA BIOLOGICS, INC. (ADMA). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Kaitlin M. Kestenberg-Messina last file a Form 4?
The most recent primary Form 4 on record is dated 29 July 2026, one of 8 filings going back to 2024.
Has Kaitlin M. Kestenberg-Messina been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($158K) across all tracked filings.
